SEC Filing Summary: Hexindai Inc. (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Hexindai Inc., a foreign private issuer, for the month of September 2018. The report was signed by Zhang Qisen (Johnson), Chief Financial Officer, on September 25, 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document consists primarily of cover page information and an exhibit index referencing a press release (Exhibit 99.1), but the financial data within that press release is not included in the provided text.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or operational updates are present in the provided content.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to administrative filing details and does not contain the substantive disclosures typically found in the referenced press release.
Key Facts for Investor Verification
- The registrant is Hexindai Inc., not Akso Health Group as indicated in the request metadata.
- The filing date is September 25, 2018, covering the month of September 2018.
- Financial performance details are absent from this text; investors must locate and review Exhibit 99.1 (Press Release) for actual data.
- The company files annual reports under Form 20-F.